News & Updates
Filter by Specialty:
STRIDE regimen benefit in unresectable HCC consistent across baseline liver function
The overall survival (OS) benefit observed with the STRIDE regimen compared with sorafenib in patients with unresectable hepatocellular carcinoma (HCC) is consistent regardless of baseline liver function, according to exploratory analysis of data from the phase III HIMALAYA trial presented at ESMO GI 2022.
STRIDE regimen benefit in unresectable HCC consistent across baseline liver function
11 Sep 2022
Spleen pull-out lymph node dissection safe for gastric cancer
The use of spleen pull-out lymph node dissection in the splenic hilum is both safe and feasible for patients with gastric cancer undergoing radical gastrectomy, a recent study has found.
Spleen pull-out lymph node dissection safe for gastric cancer
11 Sep 2022
Dactylitis predicts more severe joint damage, higher disease activity in axPsA
The presence of dactylitis in patients with axial psoriatic arthritis (axPsA) may result in higher disease activity and more severe joint damage compared to those without, reports a study.
Dactylitis predicts more severe joint damage, higher disease activity in axPsA
10 Sep 2022
Male sex tied to better outcomes in early ACPA-negative rheumatoid arthritis
Men with anticitrullinated peptide antibody (ACPA)-negative early rheumatoid arthritis (RA) tend to have favourable clinical outcomes than their female counterparts, a study has shown. However, such benefit is not seen in those with ACPA-positive early RA.